About Evysaif
At EvySaif, we believe science is only as powerful as the way it is communicated and applied. In today’s complex healthcare and life sciences ecosystem, organizations need more than content. They need a clinician-led partner who turns dense clinical and scientific data into clarity, credibility, and decisions that stand up to scrutiny, from the study protocol to the regulator and the payer.
EvySaif is a specialized, clinician-led medical, scientific, and regulatory consultancy based in Pune, India, serving pharmaceutical, biotech, medical device, and healthcare organizations across India, the Middle East, Europe, and beyond. We exist to bridge the gap between evidence and engagement, taking the data your teams generate and shaping it into the documents, regulatory submissions, strategies, and communications that are scientifically accurate, compliant, and genuinely useful to the people who read them.
What sets us apart begins with how we are led. EvySaif was founded and is led by a qualified clinical pharmacist with hands-on hospital clinical experience spanning infectious disease, oncology, analgesia, critical care, and precision medicine, alongside a record of peer-reviewed publications. That means your work is not just written to a template. It is shaped by someone who has practiced at the bedside, interpreted clinical evidence under real conditions, and understands what a regulator, a payer, a journal reviewer, or a treating physician actually needs to see. This clinical grounding runs through everything we produce and is the reason our documents read as sound science, not just polished text.
We work as an extension of your team, whether you need a single deliverable or an integrated evidence and submission program spanning many. We adapt to your templates, your timelines, and your target markets, and we hold every deliverable to the same standard regardless of size. EvySaif is one of the best research and medical writing consultancies in India, and we bring that standard to every engagement, for the smallest abstract and the largest regulatory dossier alike.
What We Do
Our work spans the full evidence and regulatory lifecycle, from designing a study to securing approval and making the case for a product, organized across connected service areas. Because the same clinical and scientific team stands behind all of them, your evidence stays consistent as it moves from one to the next.
Scientific, Medical & Regulatory Writing
Protocols, CSRs to ICH E3, safety reports, and CTD/eCTD submissions, with regulatory consultancy across the FDA, EMA, MHRA, CDSCO, and other major authorities worldwide.
Health Economics & Outcomes Research
Cost-effectiveness and budget impact modeling, systematic reviews, and value dossiers built to CHEERS 2022 and PRISMA 2020 for HTA and market access.
Publications & Research Support
Manuscripts, abstracts, posters, and publication planning grounded in rigorous evidence synthesis and Good Publication Practice.
Scientific Communication & Engagement
Medical education content, congress and symposia materials, and scientific narratives that translate complex data for the right audience.
Medical Affairs Solutions
Medical information and standard response documents, advisory board support, MSL enablement content, and medical affairs strategy as compliant scientific exchange.
Why EvySaif
Clinician-led at the core.
Your work is handled and reviewed by a qualified clinical pharmacist with direct clinical experience across infectious disease, oncology, analgesia, critical care, and precision medicine, so the clinical substance is sound, not just the formatting. This is the difference between a document that reads well and one that holds up when a regulator, payer, or reviewer examines it closely.
A genuine track record, not just capability.
Our team has authored first-in-human clinical trial protocols, prepared regulatory submission documents and IVD performance evaluation files for Indian and European markets, built health economic models rigorous enough for peer-reviewed publication, and delivered oncology advisory board programs end to end. We speak from delivered work, not theory.
Built to recognized standards.
We write and advise to the frameworks that regulators, payers, and journals actually expect, including ICH guidelines (GCP, safety, and quality), Good Pharmacovigilance Practices (GVP), CHEERS 2022, PRISMA 2020, the EU IVDR and MDR, and India's CDSCO requirements. Standards are the starting point of our work, not an afterthought.
Made for your market, across regions.
With direct experience across India, the Middle East, Europe, and other regulated markets, we adapt every deliverable to the regulatory and payer reality of where you operate. This matters more each year as Gulf and Indian requirements continue to formalize, from mandatory economic evaluation in Saudi Arabia to evolving marketing and compliance codes in India.
Honest and rigorous.
We give you clear, critical input rather than easy validation, targeted edits over cosmetic rewrites, and documents designed to withstand scrutiny from the people who review them. If something in your evidence, benefit-risk argument, or submission does not hold, we tell you before your reviewers do.
One partner across the lifecycle.
Because we cover regulatory affairs, scientific and medical writing, medical affairs, and health economics under one roof, your evidence, strategy, submissions, and communications stay aligned instead of fragmented across multiple vendors. One team, one standard, one consistent scientific story from protocol to approval to market access.
Our Philosophy
Our Promise
We have world class pathologists & Lab assistants. We are equipped with best laboratory machinery & reagents. We ensure best quality findings.
Clients Testimonial
Dr. Ananya Mehta
James Carter